CUE BIOPHARMA INC (CUE)
US22978P1066 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -44.61M | -50.73M | -53.01M | -44.16M | -44.78M | |||
| Depreciation Amortization | 415.00K | 556.00K | 920.00K | 1.26M | 1.06M | |||
| Change In Working Capital | -4.95M | -1.36M | 750.00K | -4.49M | 1.24M | |||
| Interest Paid | 780.00K | 1.00M | 570.00K | N/A | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 10.90M | 11.58M | 9.53M | 8.56M | 10.00M | |||
| OPERATING CASH FLOW | -38.26M | -39.96M | -41.81M | -38.84M | -32.49M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -64.00K | 0.00 | -170.00K | -910.00K | -600.00K | |||
| Other Investing Activity | 99.00K | 25.00M | -24.44M | 10.02M | 5.05M | |||
| INVESTING CASH FLOW | 35.00K | 25.00M | -24.61M | 9.11M | 4.46M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 5.13M | 11.39M | 26.60M | N/A | N/A | |||
| Stock Issued/Repurchased | 10.82M | 473.00K | 27.20M | 19.23M | 58.61M | |||
| Other Financing Activity | N/A | 0.00 | -140.00K | 0.00 | 0.00 | |||
| FINANCING CASH FLOW | 15.96M | 11.86M | 53.66M | 19.23M | 58.61M | |||
| CHANGE IN CASH | -22.27M | -3.10M | -12.76M | -10.50M | 30.58M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -38.26M | -39.96M | -41.81M | -38.84M | -32.49M | |||
| Capital Expenditure | -64.00K | 0.00 | -170.00K | -910.00K | -600.00K | |||
| FREE CASH FLOW | -38.33M | -39.96M | -41.98M | -39.75M | -33.09M | |||
All data in USD